{
    "xml": "<topic id=\"PHP3510\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/erythromycin\" basename=\"erythromycin\" title=\"ERYTHROMYCIN\">\n<title>ERYTHROMYCIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_169\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/erythromycin\">Erythromycin</xref>\n</p>\n<data name=\"vtmid\">30427009</data>\r\n<data name=\"vtmid\">419088007</data>\r\n<data name=\"vtmid\">420446003</data>\r\n<data name=\"vtmid\">421270007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_616564198\" title=\"Macrolides and related drugs\">Macrolides and related drugs</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34517\" title=\"MACROLIDES\" namespace=\"/drug-classes/macrolides\">MACROLIDES</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP36320\" outputclass=\"indicationsAndDose\" rev=\"1.82\" parent=\"/drugs/erythromycin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Susceptible infections in patients with penicillin hypersensitivity (e.g. respiratory-tract infections (including Legionella infection), skin and oral infections, and campylobacter enteritis)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>125&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 250&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;7 years</p>\n<p>250&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 8&#8211;17 years</p>\n<p>250&#8211;500&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>250&#8211;500&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>12.5&#8239;mg/kg every 6&#8239;hours (max. per dose 1&#8239;g).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>6.25&#8239;mg/kg every 6&#8239;hours, for mild infections when oral treatment not possible. increased to 12.5&#8239;mg/kg every 6&#8239;hours, dose increase may be used in severe infections.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Lyme disease</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg 4 times a day for 14&#8211;21 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Early syphilis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg 4 times a day for 14 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Uncomplicated genital chlamydia</p>\n<p outputclass=\"therapeuticIndication\">Non-gonococcal urethritis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg twice daily for 14 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Chronic prostatitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>250&#8211;500&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 4&#8239;g daily in divided doses, dose increase may be used severe infections.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>6.25&#8239;mg/kg every 6&#8239;hours, for mild infections when oral treatment is not possible, increased to 12.5&#8239;mg/kg every 6&#8239;hours, dose increase may be used in severe infections.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention and treatment of pertussis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>125&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 250&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;7 years</p>\n<p>250&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 8&#8211;17 years</p>\n<p>250&#8211;500&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>(consult local protocol).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of secondary case of diphtheria in non-immune patient</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>125&#8239;mg every 6&#8239;hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;7 years</p>\n<p>250&#8239;mg every 6&#8239;hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 8&#8211;17 years</p>\n<p>500&#8239;mg every 6&#8239;hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg every 6&#8239;hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of secondary case of invasive group A streptococcal infection in penicillin allergic patients</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>125&#8239;mg every 6&#8239;hours for 10 days.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;7 years</p>\n<p>250&#8239;mg every 6&#8239;hours for 10 days.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 8&#8211;17 years</p>\n<p>250&#8211;500&#8239;mg every 6&#8239;hours for 10 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>250&#8211;500&#8239;mg every 6&#8239;hours for 10 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of pneumococcal infection in asplenia or in patients with sickle-cell disease, and who are penicillin allergic</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>125&#8239;mg twice daily, antibiotic prophylaxis is not fully reliable.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;7 years</p>\n<p>125&#8239;mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 8&#8211;17 years</p>\n<p>500&#8239;mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of recurrence of rheumatic fever</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>125&#8239;mg twice daily.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;17 years</p>\n<p>250&#8239;mg twice daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Rosacea</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg twice daily courses usually last 6&#8211;12 weeks and are repeated intermittently.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Acne</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg twice daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36243\" outputclass=\"unlicensedUse\" rev=\"1.27\" parent=\"/drugs/erythromycin\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use or <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>Not licensed for use in gastro-intestinal stasis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36404\" outputclass=\"cautions\" rev=\"1.40\" parent=\"/drugs/erythromycin\">\n<title>Cautions</title>\n<body>\r\n<section outputclass=\"cautions\">\r\n<sectiondiv outputclass=\"additionalCautions\">\r\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\r\n<p outputclass=\"title\">With systemic use</p>\r\n<p>\r\n<ph outputclass=\"caution\">avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"caution\">neonate under 2 weeks (risk of hypertrophic pyloric stenosis)</ph> (in neonates)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP36312\" outputclass=\"interactions\" rev=\"1.19\" parent=\"/drugs/erythromycin\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>See Appendix 1 (macrolides).</p>\n<p>Caution with concomitant use of drugs that prolong the QT interval.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use</p>\n<p>Interactions do not apply to small amounts of erythromycin used topically.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36306\" outputclass=\"pregnancy\" parent=\"/drugs/erythromycin\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>Not known to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36416\" outputclass=\"breastFeeding\" parent=\"/drugs/erythromycin\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>Only small amounts in milk&#8212;not known to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36332\" outputclass=\"hepaticImpairment\" parent=\"/drugs/erythromycin\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>May cause idiosyncratic hepatotoxicity.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36291\" outputclass=\"renalImpairment\" parent=\"/drugs/erythromycin\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use in adults</p>\n<p>Max. 1.5&#8239;g daily in severe renal impairment (ototoxicity).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use in children</p>\n<p>Reduce dose in severe renal impairment (ototoxicity).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36442\" outputclass=\"directionsForAdministration\" rev=\"1.23\" parent=\"/drugs/erythromycin\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>Dilute reconstituted solution further in glucose 5% (neutralised with Sodium bicarbonate) or sodium chloride 0.9% to a concentration of 1&#8211;5&#8239;mg/mL; give over 20&#8211;60 minutes.</p>\n<p>Concentration of up to 10&#8239;mg/mL may be used in fluid-restriction if administered via a central venous catheter.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i> (as lactobionate), give intermittently <i>in</i> Glucose 5% (neutralised with sodium bicarbonate) <i>or</i> Sodium chloride 0.9%; dissolve initially in water for injections (1&#8239;g in 20&#8239;mL) then dilute to a concentration of 1&#8211;5&#8239;mg/mL; give over 20&#8211;60 minutes.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58303\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.35\" parent=\"/drugs/erythromycin\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>Flavours of oral liquid formulations may include banana.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36299\" outputclass=\"patientAndCarerAdvice\" rev=\"1.12\" parent=\"/drugs/erythromycin\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Erythromycin for bacterial infections</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/erythromycin-for-bacterial-infections\">www.medicinesforchildren.org.uk/erythromycin-for-bacterial-infections</xref>\n</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP36171\" outputclass=\"professionSpecificInformation\" rev=\"1.20\" parent=\"/drugs/erythromycin\">\n<title>Profession specific information</title>\n<body>\n<section outputclass=\"dentalPractitionersFormulary\">\n<title>Dental practitioners' formulary</title>\n<sectiondiv>\n<p>Erythromycin tablets e/c may be prescribed.</p>\n<p>Erythromycin ethyl succinate oral suspension may be prescribed.</p>\n<p>Erythromycin stearate tablets may be prescribed.</p>\n<p>Erythromycin ethyl succinate tablets may be prescribed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3510-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/erythromycin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: gel, ointment</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75527\" title=\"Tablet\" namespace=\"/drugs/erythromycin/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75541\" title=\"Gastro-resistant tablet\" namespace=\"/drugs/erythromycin/gastro-resistant-tablet\">Gastro-resistant tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75534\" title=\"Gastro-resistant capsule\" namespace=\"/drugs/erythromycin/gastro-resistant-capsule\">Gastro-resistant capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75520\" title=\"Oral suspension\" namespace=\"/drugs/erythromycin/oral-suspension\">Oral suspension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75514\" title=\"Powder for solution for infusion\" namespace=\"/drugs/erythromycin/powder-for-solution-for-infusion\">Powder for solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75549\" title=\"Liquid\" namespace=\"/drugs/erythromycin/liquid\">Liquid</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP88053\" namespace=\"/drugs/erythromycin-with-isotretinoin\" title=\"ERYTHROMYCIN WITH ISOTRETINOIN\" count=\"1\" rel=\"backlink\">ERYTHROMYCIN WITH ISOTRETINOIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP88054\" namespace=\"/drugs/erythromycin-with-tretinoin\" title=\"ERYTHROMYCIN WITH TRETINOIN\" count=\"1\" rel=\"backlink\">ERYTHROMYCIN WITH TRETINOIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP98619\" namespace=\"/guidance/prescribing-in-dental-practice\" title=\"Prescribing in dental practice\" count=\"2\" rel=\"backlink\">Prescribing in dental practice</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78097\" namespace=\"/treatment-summaries/tetracyclines\" title=\"Tetracyclines\" count=\"1\" rel=\"backlink\">Tetracyclines</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78125\" namespace=\"/treatment-summaries/gastro-intestinal-system-infections-bacterial\" title=\"Gastro-intestinal system infections, bacterial\" count=\"1\" rel=\"backlink\">Gastro-intestinal system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78140\" namespace=\"/treatment-summaries/oral-bacterial-infections\" title=\"Oral bacterial infections\" count=\"1\" rel=\"backlink\">Oral bacterial infections</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78166\" namespace=\"/treatment-summaries/diabetes\" title=\"Diabetes\" count=\"1\" rel=\"backlink\">Diabetes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78210\" namespace=\"/treatment-summaries/antibacterials-use-for-prophylaxis\" title=\"Antibacterials, use for prophylaxis\" count=\"4\" rel=\"backlink\">Antibacterials, use for prophylaxis</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78307\" namespace=\"/treatment-summaries/rosacea-and-acne\" title=\"Rosacea and Acne\" count=\"6\" rel=\"backlink\">Rosacea and Acne</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78436\" namespace=\"/treatment-summaries/skin-infections-bacterial\" title=\"Skin infections, bacterial\" count=\"4\" rel=\"backlink\">Skin infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78449\" namespace=\"/treatment-summaries/ear-infections-bacterial\" title=\"Ear infections, bacterial\" count=\"2\" rel=\"backlink\">Ear infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78459\" namespace=\"/treatment-summaries/nose-infections-bacterial\" title=\"Nose infections, bacterial\" count=\"1\" rel=\"backlink\">Nose infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78462\" namespace=\"/treatment-summaries/macrolides\" title=\"Macrolides\" count=\"8\" rel=\"backlink\">Macrolides</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78479\" namespace=\"/treatment-summaries/oropharynx-infections-bacterial\" title=\"Oropharynx infections, bacterial\" count=\"1\" rel=\"backlink\">Oropharynx infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78529\" namespace=\"/treatment-summaries/genital-system-infections-bacterial\" title=\"Genital system infections, bacterial\" count=\"2\" rel=\"backlink\">Genital system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78577\" namespace=\"/treatment-summaries/respiratory-system-infections-bacterial\" title=\"Respiratory system infections, bacterial\" count=\"10\" rel=\"backlink\">Respiratory system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78609\" namespace=\"/treatment-summaries/ear\" title=\"Ear\" count=\"1\" rel=\"backlink\">Ear</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_169\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/erythromycin\" title=\"Erythromycin\" count=\"1\" rel=\"link\">Erythromycin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34517\" namespace=\"/drug-classes/macrolides\" title=\"MACROLIDES\" count=\"1\" rel=\"link\">MACROLIDES</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75527\" namespace=\"/drugs/erythromycin/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75541\" namespace=\"/drugs/erythromycin/gastro-resistant-tablet\" title=\"Gastro-resistant tablet\" count=\"1\" rel=\"link\">Gastro-resistant tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75534\" namespace=\"/drugs/erythromycin/gastro-resistant-capsule\" title=\"Gastro-resistant capsule\" count=\"1\" rel=\"link\">Gastro-resistant capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75520\" namespace=\"/drugs/erythromycin/oral-suspension\" title=\"Oral suspension\" count=\"1\" rel=\"link\">Oral suspension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75514\" namespace=\"/drugs/erythromycin/powder-for-solution-for-infusion\" title=\"Powder for solution for infusion\" count=\"1\" rel=\"link\">Powder for solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75549\" namespace=\"/drugs/erythromycin/liquid\" title=\"Liquid\" count=\"1\" rel=\"link\">Liquid</xref>\n</links>\n</topic>",
    "id": "PHP3510",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/erythromycin",
    "basename": "erythromycin",
    "title": "ERYTHROMYCIN",
    "interactants": [
        {
            "id": "bnf_int_169",
            "label": "Erythromycin"
        }
    ],
    "vtmid": "421270007",
    "drugClassification": [
        "Macrolides and related drugs"
    ],
    "inheritsFromClass": [
        "MACROLIDES"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Susceptible infections in patients with penicillin hypersensitivity (e.g. respiratory-tract infections (including Legionella infection), skin and oral infections, and campylobacter enteritis)",
                        "html": "Susceptible infections in patients with penicillin hypersensitivity (e.g. respiratory-tract infections (including Legionella infection), skin and oral infections, and campylobacter enteritis)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "125 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 250 mg 4 times a day, dose increase may be used in severe infections.",
                        "html": "<p>125&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 250&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "250 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500 mg 4 times a day, dose increase may be used in severe infections.",
                        "html": "<p>250&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>",
                        "ageGroup": "2&#8211;7 years"
                    },
                    {
                        "textContent": "250&#8211;500 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000 mg 4 times a day, dose increase may be used in severe infections.",
                        "html": "<p>250&#8211;500&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>",
                        "ageGroup": "8&#8211;17 years"
                    },
                    {
                        "textContent": "12.5 mg/kg every 6 hours (max. per dose 1 g).",
                        "html": "<p>12.5&#8239;mg/kg every 6&#8239;hours (max. per dose 1&#8239;g).</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "250&#8211;500 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000 mg 4 times a day, dose increase may be used in severe infections.",
                        "html": "<p>250&#8211;500&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>"
                    },
                    {
                        "textContent": "6.25 mg/kg every 6 hours, for mild infections when oral treatment not possible. increased to 12.5 mg/kg every 6 hours, dose increase may be used in severe infections.",
                        "html": "<p>6.25&#8239;mg/kg every 6&#8239;hours, for mild infections when oral treatment not possible. increased to 12.5&#8239;mg/kg every 6&#8239;hours, dose increase may be used in severe infections.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Lyme disease",
                        "html": "Lyme disease"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 mg 4 times a day for 14&#8211;21 days.",
                        "html": "<p>500&#8239;mg 4 times a day for 14&#8211;21 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Early syphilis",
                        "html": "Early syphilis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 mg 4 times a day for 14 days.",
                        "html": "<p>500&#8239;mg 4 times a day for 14 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Uncomplicated genital chlamydia",
                        "html": "Uncomplicated genital chlamydia"
                    },
                    {
                        "textContent": "Non-gonococcal urethritis",
                        "html": "Non-gonococcal urethritis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 mg twice daily for 14 days.",
                        "html": "<p>500&#8239;mg twice daily for 14 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Chronic prostatitis",
                        "html": "Chronic prostatitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "250&#8211;500 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 4 g daily in divided doses, dose increase may be used severe infections.",
                        "html": "<p>250&#8211;500&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 4&#8239;g daily in divided doses, dose increase may be used severe infections.</p>"
                    },
                    {
                        "textContent": "6.25 mg/kg every 6 hours, for mild infections when oral treatment is not possible, increased to 12.5 mg/kg every 6 hours, dose increase may be used in severe infections.",
                        "html": "<p>6.25&#8239;mg/kg every 6&#8239;hours, for mild infections when oral treatment is not possible, increased to 12.5&#8239;mg/kg every 6&#8239;hours, dose increase may be used in severe infections.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention and treatment of pertussis",
                        "html": "Prevention and treatment of pertussis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "125 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 250 mg 4 times a day, dose increase may be used in severe infections.",
                        "html": "<p>125&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 250&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "250 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500 mg 4 times a day, dose increase may be used in severe infections.",
                        "html": "<p>250&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>",
                        "ageGroup": "2&#8211;7 years"
                    },
                    {
                        "textContent": "250&#8211;500 mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000 mg 4 times a day, dose increase may be used in severe infections.",
                        "html": "<p>250&#8211;500&#8239;mg 4 times a day, total daily dose may alternatively be given in two divided doses, increased to 500&#8211;1000&#8239;mg 4 times a day, dose increase may be used in severe infections.</p>",
                        "ageGroup": "8&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "(consult local protocol).",
                        "html": "<p>(consult local protocol).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of secondary case of diphtheria in non-immune patient",
                        "html": "Prevention of secondary case of diphtheria in non-immune patient"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "125 mg every 6 hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.",
                        "html": "<p>125&#8239;mg every 6&#8239;hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "250 mg every 6 hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.",
                        "html": "<p>250&#8239;mg every 6&#8239;hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</p>",
                        "ageGroup": "2&#8211;7 years"
                    },
                    {
                        "textContent": "500 mg every 6 hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.",
                        "html": "<p>500&#8239;mg every 6&#8239;hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</p>",
                        "ageGroup": "8&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "500 mg every 6 hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.",
                        "html": "<p>500&#8239;mg every 6&#8239;hours for 7 days, treat for further 10 days if nasopharyngeal swabs positive after first 7 days' treatment.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of secondary case of invasive group A streptococcal infection in penicillin allergic patients",
                        "html": "Prevention of secondary case of invasive group A streptococcal infection in penicillin allergic patients"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "125 mg every 6 hours for 10 days.",
                        "html": "<p>125&#8239;mg every 6&#8239;hours for 10 days.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "250 mg every 6 hours for 10 days.",
                        "html": "<p>250&#8239;mg every 6&#8239;hours for 10 days.</p>",
                        "ageGroup": "2&#8211;7 years"
                    },
                    {
                        "textContent": "250&#8211;500 mg every 6 hours for 10 days.",
                        "html": "<p>250&#8211;500&#8239;mg every 6&#8239;hours for 10 days.</p>",
                        "ageGroup": "8&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "250&#8211;500 mg every 6 hours for 10 days.",
                        "html": "<p>250&#8211;500&#8239;mg every 6&#8239;hours for 10 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of pneumococcal infection in asplenia or in patients with sickle-cell disease, and who are penicillin allergic",
                        "html": "Prevention of pneumococcal infection in asplenia or in patients with sickle-cell disease, and who are penicillin allergic"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "125 mg twice daily, antibiotic prophylaxis is not fully reliable.",
                        "html": "<p>125&#8239;mg twice daily, antibiotic prophylaxis is not fully reliable.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "125 mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.",
                        "html": "<p>125&#8239;mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.</p>",
                        "ageGroup": "2&#8211;7 years"
                    },
                    {
                        "textContent": "500 mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.",
                        "html": "<p>500&#8239;mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.</p>",
                        "ageGroup": "8&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "500 mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.",
                        "html": "<p>500&#8239;mg twice daily, antibiotic prophylaxis is not fully reliable. It may be discontinued in those over 5 years of age with sickle-cell disease who have received pneumococcal immunisation and who do not have a history of severe pneumococcal infection.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of recurrence of rheumatic fever",
                        "html": "Prevention of recurrence of rheumatic fever"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "125 mg twice daily.",
                        "html": "<p>125&#8239;mg twice daily.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "250 mg twice daily.",
                        "html": "<p>250&#8239;mg twice daily.</p>",
                        "ageGroup": "2&#8211;17 years"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Rosacea",
                        "html": "Rosacea"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 mg twice daily courses usually last 6&#8211;12 weeks and are repeated intermittently.",
                        "html": "<p>500&#8239;mg twice daily courses usually last 6&#8211;12 weeks and are repeated intermittently.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Acne",
                        "html": "Acne"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 mg twice daily.",
                        "html": "<p>500&#8239;mg twice daily.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With intravenous use or oral use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use or <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous",
                        "oral"
                    ]
                },
                "textContent": "Not licensed for use in gastro-intestinal stasis.",
                "html": "<p>Not licensed for use in gastro-intestinal stasis.</p>"
            }
        ]
    },
    "cautions": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid in Acute porphyrias",
                "html": "avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With systemic use",
                    "routes": [
                        "systemic"
                    ]
                },
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "neonate under 2 weeks (risk of hypertrophic pyloric stenosis) in neonates",
                "html": "neonate under 2 weeks (risk of hypertrophic pyloric stenosis) in neonates",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With systemic use",
                    "routes": [
                        "systemic"
                    ],
                    "patientType": "neonates"
                }
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "See Appendix 1 (macrolides).\n\nCaution with concomitant use of drugs that prolong the QT interval.",
                "html": "<p>See Appendix 1 (macrolides).</p><p>Caution with concomitant use of drugs that prolong the QT interval.</p>"
            },
            {
                "type": "general",
                "specificity": {
                    "textContent": "With topical use",
                    "html": "With <ph outputclass=\"route\">topical</ph> use",
                    "routes": [
                        "topical"
                    ]
                },
                "textContent": "Interactions do not apply to small amounts of erythromycin used topically.",
                "html": "<p>Interactions do not apply to small amounts of erythromycin used topically.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Not known to be harmful.",
                "html": "<p>Not known to be harmful.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Only small amounts in milk&#8212;not known to be harmful.",
                "html": "<p>Only small amounts in milk&#8212;not known to be harmful.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "May cause idiosyncratic hepatotoxicity.",
                "html": "<p>May cause idiosyncratic hepatotoxicity.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With systemic use in adults",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Max. 1.5 g daily in severe renal impairment (ototoxicity).",
                "html": "<p>Max. 1.5&#8239;g daily in severe renal impairment (ototoxicity).</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With systemic use in children",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Reduce dose in severe renal impairment (ototoxicity).",
                "html": "<p>Reduce dose in severe renal impairment (ototoxicity).</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Dilute reconstituted solution further in glucose 5% (neutralised with Sodium bicarbonate) or sodium chloride 0.9% to a concentration of 1&#8211;5 mg/mL; give over 20&#8211;60 minutes.\n\nConcentration of up to 10 mg/mL may be used in fluid-restriction if administered via a central venous catheter.",
                "html": "<p>Dilute reconstituted solution further in glucose 5% (neutralised with Sodium bicarbonate) or sodium chloride 0.9% to a concentration of 1&#8211;5&#8239;mg/mL; give over 20&#8211;60 minutes.</p><p>Concentration of up to 10&#8239;mg/mL may be used in fluid-restriction if administered via a central venous catheter.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (as lactobionate), give intermittently in Glucose 5% (neutralised with sodium bicarbonate) or Sodium chloride 0.9%; dissolve initially in water for injections (1 g in 20 mL) then dilute to a concentration of 1&#8211;5 mg/mL; give over 20&#8211;60 minutes.",
                "html": "<p>For <i>intravenous infusion</i> (as lactobionate), give intermittently <i>in</i> Glucose 5% (neutralised with sodium bicarbonate) <i>or</i> Sodium chloride 0.9%; dissolve initially in water for injections (1&#8239;g in 20&#8239;mL) then dilute to a concentration of 1&#8211;5&#8239;mg/mL; give over 20&#8211;60 minutes.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Flavours of oral liquid formulations may include banana.",
                "html": "<p>Flavours of oral liquid formulations may include banana.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/erythromycin-for-bacterial-infections",
                        "label": "www.medicinesforchildren.org.uk/erythromycin-for-bacterial-infections"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Erythromycin for bacterial infections",
                "textContent": "www.medicinesforchildren.org.uk/erythromycin-for-bacterial-infections",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/erythromycin-for-bacterial-infections\">www.medicinesforchildren.org.uk/erythromycin-for-bacterial-infections</xref>\n</p>"
            }
        ]
    },
    "professionSpecificInformation": {
        "dentalPractitionersFormulary": [
            {
                "type": "dentalPractitionersFormulary",
                "textContent": "Erythromycin tablets e/c may be prescribed.\n\nErythromycin ethyl succinate oral suspension may be prescribed.\n\nErythromycin stearate tablets may be prescribed.\n\nErythromycin ethyl succinate tablets may be prescribed.",
                "html": "<p>Erythromycin tablets e/c may be prescribed.</p><p>Erythromycin ethyl succinate oral suspension may be prescribed.</p><p>Erythromycin stearate tablets may be prescribed.</p><p>Erythromycin ethyl succinate tablets may be prescribed.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "gel",
                "ointment"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75527",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75541",
                "label": "Gastro-resistant tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75534",
                "label": "Gastro-resistant capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75520",
                "label": "Oral suspension",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75514",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75549",
                "label": "Liquid",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP88053",
                "label": "ERYTHROMYCIN WITH ISOTRETINOIN",
                "type": "drug"
            },
            {
                "id": "PHP88054",
                "label": "ERYTHROMYCIN WITH TRETINOIN",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP98619",
                "label": "Prescribing in dental practice",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78097",
                "label": "Tetracyclines",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78125",
                "label": "Gastro-intestinal system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78140",
                "label": "Oral bacterial infections",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78166",
                "label": "Diabetes",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78210",
                "label": "Antibacterials, use for prophylaxis",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78307",
                "label": "Rosacea and Acne",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78436",
                "label": "Skin infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78449",
                "label": "Ear infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78459",
                "label": "Nose infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78462",
                "label": "Macrolides",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78479",
                "label": "Oropharynx infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78529",
                "label": "Genital system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78577",
                "label": "Respiratory system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78609",
                "label": "Ear",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_169",
                "label": "Erythromycin",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34517",
                "label": "MACROLIDES",
                "type": "drugClass"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75527",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75541",
                "label": "Gastro-resistant tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75534",
                "label": "Gastro-resistant capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75520",
                "label": "Oral suspension",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75514",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75549",
                "label": "Liquid",
                "type": "medicinalForm"
            }
        ]
    }
}